PMID: 8604170Jan 17, 1996Paper

Trends in infectious diseases mortality in the United States

JAMA : the Journal of the American Medical Association
R W PinnerR L Berkelman

Abstract

To evaluate recent trends in infectious diseases mortality in the United States. Descriptive study of infectious disease mortality, classifying International Classification of Diseases, Ninth Revision codes as infectious diseases, consequence of infectious diseases, or not infectious diseases. Multiple cause-of-death tapes from the National Center for Health Statistics for the years 1980 through 1992 were used, with a focus on underlying cause-of-death data and on codes that exclusively represent infectious diseases. United States. All persons who died between 1980 and 1992. Death. Between 1980 and 1992, the death rate due to infectious diseases as the underlying cause of death increased 58%, from 41 to 65 deaths per 100,000 population in the United States. Age-adjusted mortality from infectious diseases increased 39% during the same period. Infectious diseases mortality increased 25% among those aged 65 years and older (from 271 to 338 per 100,000), and 6.3 times among 25- to 44-year-olds (from six to 38 deaths per 100,000). Mortality due to respiratory tract infections increased 20%, from 25 to 30 deaths per 100,000, deaths attributed to human immunodeficiency virus increased from virtually none to 13 per 100,000 in 1992, and...Continue Reading

Citations

Mar 18, 2008·The Journal of Antimicrobial Chemotherapy·Brian G OliverTheodore C White
Mar 2, 2002·The Lancet Infectious Diseases·S HarbarthJ Huebner
Apr 24, 2014·American Journal of Public Health·James E CheekThomas W Hennessy
Apr 23, 2014·Emerging Infectious Diseases·Teresa López-CuadradoRafael Fernández-Cuenca
Sep 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Raina T GaySimin Nikbin Meydani
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan Jelrik OosterheertMarc J M Bonten
Oct 1, 1996·Emerging Infectious Diseases·M A Winker
Jun 1, 1997·American Journal of Public Health·S H EbrahimM L Kamb
Aug 26, 1998·Emerging Infectious Diseases·J M Hughes
Dec 10, 1999·American Journal of Public Health·J H DiLiberti, C R Jackson
Mar 10, 2001·American Journal of Public Health·R C HolmanL B Schonberger
Aug 14, 2001·American Journal of Public Health·J H Richardus, A E Kunst
Aug 31, 2002·Journal of Clinical Microbiology·Karen C Carroll
Feb 6, 2002·The Journal of Clinical Investigation·Douglas D BannermanJohn M Harlan
Apr 14, 2004·Emerging Infectious Diseases·Mitchell I WolfeSteven S Yoon
Oct 30, 2004·American Journal of Public Health·Geraldine M McQuillanRaynard S Kington
Jul 19, 2006·Clinical Microbiology Reviews·Jeffrey S Kahn
Dec 31, 2010·International Journal of General Medicine·Fuminori SakaiKeisuke Sunakawa
Aug 13, 2011·Critical Care : the Official Journal of the Critical Care Forum·Eyal BraunZaher S Azzam
Aug 27, 2011·BMC Complementary and Alternative Medicine·Jules C N AssobVeronique B Penlap
Sep 5, 2001·ILAR Journal·Borna Mehrad, Theodore J. Standiford
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A S Fauci
Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L R PetersonR B Thomson
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J G BartlettM J Fine
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergJohn E Edwards
Sep 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anke H W BrunsAndy I M Hoepelman
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergUNKNOWN Infectious Diseases Society of America
Jan 17, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard G WunderinkJean Chastre
Jul 15, 2003·American Journal of Respiratory and Critical Care Medicine·Joseph P MizgerdGeorge P Topulos
Apr 27, 2013·Médecine et maladies infectieuses·F BruyèreJ-M Benoit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.